Evidence map›Paper›PMID 34360461›Full record

ArticleInternational journal of environmental research and public health2021

Differential Impacts of Multimorbidity on COVID-19 Severity across the Socioeconomic Ladder in Hong Kong: A Syndemic Perspective.

Gary Ka-Ki Chung, Siu-Ming Chan, Yat-Hang Chan, Terry Cheuk-Fung Yip, Hon-Ming Ma, Grace Lai-Hung Wong, Roger Yat-Nork Chung, Hung Wong, Samuel Yeung-Shan Wong, Eng Kiong Yeoh and 2 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Conceptualizing COVID-19 syndemics: A scoping review.Journal of multimorbidity and comorbidity
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gary Ka-Ki ChungCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-8652-212X
Siu-Ming ChanCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-0580-289X
Yat-Hang ChanCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
Terry Cheuk-Fung YipDepartment of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
Hon-Ming MaDepartment of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
Grace Lai-Hung WongDepartment of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
Roger Yat-Nork ChungCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-4407-8208
Hung WongCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-8326-9766
Samuel Yeung-Shan WongCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-0934-6385
Eng Kiong YeohCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
Michael MarmotCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
Jean WooCUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-7593-3081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severity of COVID-19 infections could be exacerbated by the epidemic of chronic diseases and underlying inequalities in social determinants of health. Nonetheless, there is scanty evidence in regions with a relatively well-controlled outbreak. This study examined the socioeconomic patterning of COVID-19 severity and its effect modification with multimorbidity in Hong Kong. 3074 local COVID-19 cases diagnosed from 5 July to 31 October 2020 were analyzed and followed up until 30 November 2020. Data on residential addresses, socio-demographic background, COVID-19 clinical conditions, and pre-existing chronic diseases of confirmed cases were retrieved from the Centre for Health Protection and the Hospital Authority. Results showed that, despite an independent adverse impact of multimorbidity on COVID-19 severity (aOR = 2.35 [95% CI = 1.72-3.19]), it varied across the socioeconomic ladder, with no significant risk among those living in the wealthiest areas (aOR = 0.80 [0.32-2.02]). Also, no significant association of the area-level income-poverty rate with severe COVID-19 was observed. In conclusion, the socioeconomic patterning of severe COVID-19 was mild in Hong Kong. Nonetheless, socioeconomic position interacted with multimorbidity to determine COVID-19 severity with a mitigated risk among the socioeconomically advantaged. Plausible explanations include the underlying socioeconomic inequalities in chronic disease management and the equity impact of the public-private dual-track healthcare system.

Indexed as

COVID-19MultimorbidityHong KongHumansPovertySARS-CoV-2Socioeconomic FactorsSyndemicCOVID-19Hong Kongmultimorbiditysocioeconomic inequalities

Identifiers

PMID34360461
PMCPMC8346110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.